2. Academic Validation
  3. Corosolic acid alleviates rheumatoid arthritis by down regulation of the NF-κB/PI3K/AKT signaling pathway

Corosolic acid alleviates rheumatoid arthritis by down regulation of the NF-κB/PI3K/AKT signaling pathway

  • Sci Rep. 2026 Mar 28;16(1):10760. doi: 10.1038/s41598-026-46070-3.
Xian Jiang # 1,  Weixi Liu # 2,  Shanqi Xu 3,  Xinling Ni 1,  Weiding Cui 4,  Zhicheng Yang 3,  Xiaodong Chen 5,  Liqun Wang 6,  Ruiping Liu 7 8
Affiliations

Affiliations

  • 1 Department of Biochemical Engineering, College of Pharmaceutical Engineering and Life Science, Changzhou University, Changzhou, 213164, Jiangsu, China.
  • 2 Department of Orthopedic Surgery, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China.
  • 3 Department of Orthopaedics, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, 213003, China.
  • 4 Nanjing Medical University, Nanjing, 210029, China.
  • 5 Department of Orthopedic Surgery, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China. [email protected].
  • 6 Department of Biochemical Engineering, College of Pharmaceutical Engineering and Life Science, Changzhou University, Changzhou, 213164, Jiangsu, China. [email protected].
  • 7 Department of Orthopaedics, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, 213003, China. [email protected].
  • 8 Changzhou Medical Center, Nanjing Medical University, Changzhou, 213003, China. [email protected].
  • # Contributed equally.
PMID: 41904314 DOI: 10.1038/s41598-026-46070-3
Abstract

Rheumatoid arthritis (RA) is an autoimmune disease characterized by synovitis. Existing treatments for RA have serious side effects. Corosolic acid (CRA) is a natural pentacyclic triterpenoid compound with anti-inflammatory potential. However, the effect of CRA on inflammation, its possible mechanism of action, and potential therapeutic effect on RA are not well understood. This study explored the CRA mechanism of treatment action on RA by evaluating the NF-κB/PI3K/Akt signaling pathway in vitro and in vivo. In vitro, fibroblast like synovial cells (FLS) from Collagen induced arthritis (CIA) rats were assessed. ELISA, western blot, and immunofluorescence techniques demonstrated CRA (6 µg/mL) to significantly inhibit FLS secretion of TNF-α, IL-1β, and IL-6, as well as downregulate the phosphorylation of NF-κB and PI3K/Akt pathways. Inhibition experiments demonstrated that NF-κB activation was upstream of PI3K/Akt activation. In vivo, after 21 days of oral administration of CRA (10 mg/kg) to CIA rats, the arthritis score, organ index, and serum inflammatory factor levels were significantly decreased. Histopathologic analysis and Micro-CT showed that CRA reduced synovial hyperplasia and bone erosion. These results indicated that CRA exerted anti-inflammatory effects by inhibition of the NF-κB/PI3K/Akt signaling pathway, providing a potential new treatment strategy for RA patients.

Supplementary Information: The online version contains supplementary material available at 10.1038/s41598-026-46070-3.

Keywords

Corosolic acid; Fibroblast like synovial cells; NF-κB; PI3K/AKT; Rheumatoid arthritis.

Figures
Products